In early July, Karolinska University Hospital issued a press release about a successful trachea transplant using synthetic tissue. It got mainstream media coverage and it was interesting, I thought, but evolutionary and not revolutionary. We had covered a Lancet paper on much the same thing in 2008. But in the course of a correspondence with a media rep she noted something important; not only was this not a traditional transplant, this was not even one where an organ was decellularized and recellularized with the patient's stem cells, it was created for the patient and in just two days.That meant no immunosuppressive drugs, at $20,000 per year, and no morbidities due to their side effects.